The future of antiplatelet therapy in cardiovascular disease

Bianca Rocca, Carlo Patrono

Risultato della ricerca: Contributo in rivistaArticolo in rivista

22 Citazioni (Scopus)


Mechanisms of platelet inhibition are reviewed with emphasis on the pharmacokinetic and pharmacodynamic determinants of clinical efficacy and safety of antiplatelet drugs. Current developments in antiplatelet therapy are discussed in relation to both primary and secondary prevention of atherothrombotic complications. Interindividual variability in response to antiplatelet agents and new drug targets are outlined within the context of optimizing the balance between the cardiovascular benefits and bleeding risks of antiplatelet therapy. Recent advances in the pharmacogenetics of thienopyridines open the realistic prospect of a personalized choice of the most appropriate antiplatelet agent and tailored dose adjustment for an individual patient.
Lingua originaleEnglish
pagine (da-a)49-61
Numero di pagine13
RivistaAnnual Review of Medicine
Stato di pubblicazionePubblicato - 2010


  • antiplatelet
  • cardiovascular


Entra nei temi di ricerca di 'The future of antiplatelet therapy in cardiovascular disease'. Insieme formano una fingerprint unica.

Cita questo